Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 65.40
+2.50 (3.97%)
Jul 31, 2025, 5:24 PM IDT
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 139.82 million as of August 1, 2025. Its market cap has increased by 49.40% in one year.
Market Cap
139.82M
Enterprise Value
190.82M
Revenue
116.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
65.40
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 139.82M, an increase of 376.76%. That is a compound annual growth rate of 26.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 139.82M | -6.01% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | 93.74M | 338.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 60.21B |
| Danel (Adir Yeoshua) | 2.76B |
| Kamada | 1.46B |
| Bait Bakfar | 1.12B |
| SofWave Medical | 884.68M |
| BrainsWay | 757.07M |
| Novolog (Pharm-Up 1966) | 710.12M |
| Ilex Medical | 675.20M |